Marshall Wace’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Marshall Wace's LLY Position: Q3 2026 in Review
Marshall Wace reduced its Eli Lilly (LLY) stake by 33% in Q3 2026, selling an estimated $132M and leaving 223,098 shares worth $258M. The position accounts for 0.23% of the portfolio, ranked #68.
Marshall Wace first reported a position in LLY in Q1 2014 and has held it in 39 quarters since. The position peaked at $1.3B in Q4 2025. 4,347 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Marshall Wace held 223,098 shares of Eli Lilly worth $258M as of Q3 2026.
- Marshall Wace sold 111,539 Eli Lilly shares in Q3 2026, an estimated $132M.
- Eli Lilly made up 0.23% of Marshall Wace's portfolio in Q3 2026, its #68 holding.
- Marshall Wace first reported a position in Eli Lilly in Q1 2014 and has held it in 39 quarters since.
- Marshall Wace's Eli Lilly position peaked at $1.3B in Q4 2025.
- 4,347 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.